Browse by author
Lookup NU author(s): Professor Phil WhiteORCiD
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY. Published by BMJ Group. This opinion piece discusses the challenges of managing a person with sight-threatening papilloedema due to idiopathic intracranial hypertension (IIH). With no available randomised controlled trials, clinicians often choose locally available surgical intervention. An increasing number of studies have advocated using dural venous sinus stenting in IIH. Big data studies show that shunts have been the mainstay of surgical treatment for IIH, and recent evidence shows improved outcomes and fewer revision surgeries. There remains genuine equipoise in the choice of intervention between shunting and dural venous stenting in IIH. The IIH Intervention Trial funded by the National Institute of Health Research is underway in the UK, the first randomised control trial to evaluate both of these surgical interventions in people with sight-threatening IIH.
Author(s): Mollan SP, Tsermoulas G, Berman G, Toma AK, Fergus R, White P, Wakerley BR, Sinclair AJ
Publication type: Article
Publication status: Published
Journal: Practical Neurology
Year: 2025
Pages: Epub ahead of print
Online publication date: 09/12/2025
Acceptance date: 05/11/2025
Date deposited: 22/12/2025
ISSN (print): 1474-7758
ISSN (electronic): 1474-7766
Publisher: BMJ Publishing Group
URL: https://doi.org/10.1136/pn-2025-004728
DOI: 10.1136/pn-2025-004728
Data Access Statement: No data are available.
Altmetrics provided by Altmetric
